FDA approves Teva’s tbo-filgrastim for severe neutropenia 30 Aug 2012Scott Beeser On August 29, 2012, the U.S. FDA approved Sicor Biotech’s BLA for tbo-filgrastim (XMO2 filgrastim), to reduce the time certain patient receiving... Read More
